Dianelys Quiñones

Prof. Dr. Dianelys Quiñones


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
DQDianelys Quiñones
Dianelys Quiñones
MAMeiji Soe Aung
Meiji Soe Aung
YCYenisel Carmona
Yenisel Carmona
MGMaría Karla González
María Karla González
NPNiurka Pereda
Niurka Pereda
NKNobumichi Kobayashi
Nobumichi Kobayashi
Increase of extraintestinal pathogenic Escherichia coli (ExPEC) showing resistance to beta-lactams is a major public health concern. This study was conducted as a first molecular epidemiological study on ExPEC in Cuba, regarding prevalence of extended-spectrum beta-lactamases (ESBLs) and carbapenemase genes. A total of 306 ExPEC isolates collected in medical institutions in 16 regions in Cuba (2014–2018) were analyzed for their genotypes and presence of genes encoding ESBL, carbapenemase, plasmid-mediated quinolone resistance (PMQR) determinants by PCR and sequencing. The most common phylogenetic group of ExPEC was B2 (49%), followed by D (23%), A (21%), and B1 (7%). Among ESBL genes detected, blaCTX-M was the most common and detected in 61% of ExPEC, with blaCTX-M-15 being dominant and distributed to all the phylogenetic groups. NDM-1 type carbapenemase gene was identified in two isolates of phylogenetic group B1-ST448. Phylogenetic group B2 ExPEC belonged to mostly ST131 (or its single-locus variant) with O25b allele, harboring blaCTX-M-27, and included an isolate of emerging type ST1193. aac (6’)-Ib-cr was the most prevalent PMQR gene (40.5%), being present in 54.5% of CTX-M-positive isolates. These results indicated high prevalence of CTX-M genes and the emergence of NDM-1 gene among recent ExPEC in Cuba, depicting an alarming situation.

31 January 2022 in MEDICC Review
Verified
Journal Article
Open access
HYHaiyang Yu
Haiyang Yu
GEGuillermo Ezpeleta-Lobato
Guillermo Ezpeleta-Lobato
XHXu Han
Xu Han
YCYenisel Carmona
Yenisel Carmona
DQDianelys Quiñones
Dianelys Quiñones
INTRODUCTION Carbapenem-resistant Acinetobacter baumannii is a complex health problem, causing difficulties in clinical–therapeutic management worldwide. It is of particular concern in Latin America, the Caribbean and China, where it is an emerging health problem. Carbapenemases produced by these organisms inactivate carbapenem antibiotics. Monitoring circulating genotypes’ geographic dispersion contributes to more effective control measures. However, exhaustive […]

16 May 2022 in MEDICC Review
Verified
Journal Article
Open access
YCYenisel Carmona
Yenisel Carmona
MHMercedes Hidalgo-Benito
Mercedes Hidalgo-Benito
LBLuisa M. Borges-Mateus
Luisa M. Borges-Mateus
NPNiurka Pereda-Novales
Niurka Pereda-Novales
MGMaría K. González-Molina
María K. González-Molina
DQDianelys Quiñones
Dianelys Quiñones
INTRODUCTION Urinary tract infection is the second-leading reason for consults in primary health care. Bacterial urinary tract infections are the most common, of which Escherichia coli is the main etiologic agent. Antimicrobial resistance and multidrug resistance complicate effective community treatment, especially if resistance is caused by extended-spectrum beta-lactamase production. WHO recommends that antimicrobial susceptibility be […]

3 March 2026 in Microbiology Spectrum
Verified
Journal Article
Open access
HJHuiqiong Jia
Huiqiong Jia
SLShaocong Lu
Shaocong Lu
YJYuanyuan Jia
Yuanyuan Jia
YYYawen Yu
Yawen Yu
YWYuye Wu
Yuye Wu
ZRZhi Ruan
Zhi Ruan
This study aims to elucidate the genomic characteristics of three Escherichia coli strains isolated from stool specimens of healthy individuals co-carrying tet (X4) and bla NDM-1 gene, which confer resistance to tigecycline and carbapenems, respectively. Whole-genome sequencing (WGS) and bioinformatic analysis were conducted to identify the genomic characteristics. Fourteen E. coli strains belonging to the same sequence type (ST) 4014, comprising eleven strains retrieved from public databases and three strains from this study, were integrated into a phylogenetic analysis. Conjugation experiments were conducted to evaluate the transferability of the resistance plasmids. Three E. coli strains exhibited resistance to both tetracyclines and carbapenems, consistent with the presence of tet (X4) and bla NDM-1 genes in their genomes. All strains belonged to the rare ST 4014 and were identified in healthy individuals within a 1-week period. WGS revealed that tet(X4) and bla NDM-1 genes were each located on separate plasmids, both exhibiting 100% sequence identity to others previously reported in various bacterial species. Conjugation experiments confirmed the transferability of both tet (X4) and bla NDM-1 -carrying plasmids. Phylogenetic analysis based on cgSNPs revealed limited genetic diversity among the three strains (2–6 SNPs), but substantial differences compared to 11 publicly available ST4014 strains (116–172 SNPs). This study reports E. coli ST4014 strains from healthy individuals harboring conjugative plasmids carrying tet (X4) and bla NDM-1 genes, conferring resistance to tigecycline and carbapenems, respectively. These findings highlight the silent spread of multidrug-resistant strains in community populations and emphasize the need for enhanced surveillance of antimicrobial resistance beyond clinical settings. IMPORTANCE: The emergence of Escherichia coli strains co-harboring tet (X4) and bla NDM-1 genes in healthy individuals represents a critical public health concern. These genes mediate resistance to tigecycline and carbapenems, two of the few remaining options for treating infections caused by multidrug-resistant gram-negative bacteria. The detection of clonally related ST4014 strains carrying conjugative plasmids encoding both resistance determinants highlights the potential for horizontal gene transfer and silent dissemination of dual-resistance plasmids in community settings. Such colonization among healthy individuals suggests that antimicrobial resistance may be spreading unnoticed beyond hospitals, driven by environmental or foodborne transmission routes. These findings emphasize the urgent need for integrated genomic surveillance and One Health-based interventions encompassing human, animal, and environmental reservoirs to prevent the expansion of high-risk resistance genes and safeguard the clinical efficacy of last-line antibiotics.